Package 47783-644-01

Brand: takhzyro

Generic: lanadelumab-flyo
NDC Package

Package Facts

Identity

Package NDC 47783-644-01
Digits Only 4778364401
Product NDC 47783-644
Product ID 47783-644_143e1cd2-1b4f-4b78-bdbf-7ac83300e34c
Description

1 VIAL, GLASS in 1 CARTON (47783-644-01) / 5 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2018-08-24
Brand takhzyro
Generic lanadelumab-flyo
Sample Package No

Linked Drug Pages (1)

TAKHZYRO ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "143e1cd2-1b4f-4b78-bdbf-7ac83300e34c", "openfda": {"nui": ["N0000192750", "N0000184151"], "unii": ["2372V1TKXK"], "rxcui": ["2055645", "2055650", "2593416", "2593419", "2629980", "2629981"], "spl_set_id": ["15f99d8c-efe7-4f7d-aa20-0d0f1e30c6e8"], "pharm_class_epc": ["Plasma Kallikrein Inhibitor [EPC]"], "pharm_class_moa": ["Kallikrein Inhibitors [MoA]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (47783-644-01)  / 5 mL in 1 VIAL, GLASS", "package_ndc": "47783-644-01", "marketing_start_date": "20180824"}], "brand_name": "TAKHZYRO", "product_id": "47783-644_143e1cd2-1b4f-4b78-bdbf-7ac83300e34c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Kallikrein Inhibitors [MoA]", "Plasma Kallikrein Inhibitor [EPC]"], "product_ndc": "47783-644", "generic_name": "lanadelumab-flyo", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAKHZYRO", "active_ingredients": [{"name": "LANADELUMAB", "strength": "300 mg/2mL"}], "application_number": "BLA761090", "marketing_category": "BLA", "marketing_start_date": "20180824", "listing_expiration_date": "20261231"}